Clinical significance of perineural invasion by prostate cancer

Published Date: 08 Mar 2023

This study examines the clinical impact of unilateral perineural invasion in prostate cancer. How does unilaterality affect long-term oncology outcomes?

Read Full News

Latest News

Conference MDAngle: AUA 2026 Metastatic Prostate Cancer

Insights from AUA 2026, including anticipated presentations, key takeaways, and how new research in metastatic prostate cancer will affect patient care.

AUA 2026: Previewing Metastatic Prostate Cancer Updates

Dr Hannah McManus looks ahead to the release of new data from phase 3 clinical trials that will inform multidisciplinary management.

Updates in Ovarian Cancer From SGO 2026

Landmark survival gains in ROSELLA and KEYNOTE-B96 in platinum-resistant disease plus pivotal data in low-grade serous ovarian cancer are highlights from SGO 2026, reported by Dr Amelia Jernigan.

A Primary Care Primer on Alzheimer’s Blood Tests

Alzheimer’s management may slowly be making its way to primary care, so The Curbsiders unpack the latest on blood-based biomarkers and antiamyloid therapies.

S3 Episode 3: Endometrial Cancer: Research, Early Detection, and Treatment

Drs Ursula Matulonis and Jessica St. Laurent discuss endometrial cancer research, funding, early detection, and treatment, including the impact of GLP-1 receptor agonists.

MASH Screening Made Simple: A 4-Step Guide

MASH is incredibly common, but easily missed. Dr Neil Skolnik breaks down the new AGA clinical pathway to help PCPs confidently screen and treat patients.

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Latest News

Insights from AUA 2026, including anticipated presentations, key takeaways, and how new research in metastatic prostate cancer will affect patient care.

Dr Hannah McManus looks ahead to the release of new data from phase 3 clinical trials that will inform multidisciplinary management.

Landmark survival gains in ROSELLA and KEYNOTE-B96 in platinum-resistant disease plus pivotal data in low-grade serous ovarian cancer are highlights from SGO 2026, reported by Dr Amelia Jernigan.

Alzheimer’s management may slowly be making its way to primary care, so The Curbsiders unpack the latest on blood-based biomarkers and antiamyloid therapies.

Drs Ursula Matulonis and Jessica St. Laurent discuss endometrial cancer research, funding, early detection, and treatment, including the impact of GLP-1 receptor agonists.

MASH is incredibly common, but easily missed. Dr Neil Skolnik breaks down the new AGA clinical pathway to help PCPs confidently screen and treat patients.

News All Time

Early PsA Detection: Biomarkers and Genetics

Dr Vinod Chandran discusses biomarkers, genetics, and clinical features that assess risk for psoriatic arthritis.

Precision Nutrition for Better Clinical Outcomes

Precision nutrition integrates genetics, the gut microbiome, metabolomics and lifestyle data to tailor dietary therapy promising better clinical outcomes.

When to Operate on a Pancreatic Cyst

More incidental pancreatic cysts are being found with modern imaging; physicians must weigh MRI surveillance against high risk surgery based on size, growth, and duct dilation.

S3 Episode 2: Endometrial Cancer Research: The Past, Present, and Future

Drs Ursula A. Matulonis and David G. Mutch discuss past and present endometrial cancer research, including the Route 66 SPORE.

S3 Episode 1: Phase 3 Trial ADCs in Endometrial Cancer

Drs Ursula Matulonis and Brian Slomovitz discuss phase 3 trials of ADCs in endometrial cancer and what's to come in the field of endometrial cancer therapeutics.

Lithium Beyond Bipolar: A New Role in Brain Health

Could lithium be more than a mood stabilizer? Dr James Greenblatt examines its emerging role in brain resilience and cognitive health.

The Thyroid Cancer Dilemma: Doing More Isn’t Always Better

With rising thyroid cancer rates but stable mortality, clinicians must weigh the costs of overdiagnosis to ensure precision care over unnecessary intervention.

S1 Episode 1: Rethinking Rhythm Control in ATTR-CM

Is rhythm control underused in ATTR-CM? Drs Kevin Alexander and Ronald Witteles make the case for rethinking how we manage arrhythmias in this disease.

S1 Episode 2: Can Early Genetic Testing Change ATTR-CM Outcomes?

Drs Kevin Alexander and Joban Vaishnav explore when and how to use genetic testing in ATTR-CM, why distinguishing hereditary from wild-type disease matters, and what this means for patients' families.

Chest Plaque Reveals Dermatofibrosarcoma in a Man

Dermatofibrosarcoma protuberans can masquerade as a benign plaque — this case requires biopsy of a 10 × 8 cm anterior chest lesion to confirm spindle cell sarcoma and guide curative surgical excision.

New ‘Breathing’ Lung-On-Chip Surprises Against Tuberculosis

Four types of lung cells — including immune cells — function together on a chip environment that simulates respiration and inhibits tuberculosis growth.

S2 Episode 6: PCR in Breast Cancer and HER2

Drs Kathy Miller and Lajos Pusztai discuss predicting which patients will have a PCR, and the impact this has on new treatments or reducing the intensity of treatments.

Therapeutic Drug Monitoring Widely Variable in Ped Rheum

In a survey, pediatric rheumatologists cite a lack of training, lack of data, turnaround time, and lab timing as barriers to broader use.

Treat the Patient, Not the Biomarker: The ctDNA Dilemma

Professor David Kerr warns against 'treating the marker' in CRC. Should rising ctDNA trigger chemo without radiologic proof?

Stress Doesn’t Cause Cancer

The mistaken belief that stress can cause cancer leads many affected individuals to blame themselves for their cancer.

Mar 20 2026 This Week in Cardiology

Listener feedback, the huge CLOSURE-AF trial of LAAC vs best medical therapy, previews of CHAMPION AF, and the controversial ACC/AHA lipid treatment guidelines are the topics John Mandrola, MD, discusses in this week's podcast.